Huawei openPangu-2.0-Pro, the first 505B open-weight AI model trained entirely on Ascend 910B NPUs, launched July 31 — but ...

Spread the loveWhen it comes to digital task management, the debate of Todoist vs Things 3 often sparks fervent discussion ...

Spread the loveWhen it comes to getting things done, most of us operate somewhere on a spectrum. On one end, you’ve got the ...

A long-term study following insomnia patients treated with cannabis-based medical products revealed sustained improvements in sleep quality, mood, and pain management over 18 months. Most participants ...

AI coding agents can accelerate development, but they may also generate bloated code and technical debt. Learn where they ...

In its early access state, No Rest for the Wicked is already full of surprises. Mostly those are great, like how one moment I found myself marveling at its slow and precise combat (all but ...

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings.

Half a year since Australia restricted social media companies from providing accounts to kids under 16, signs of success are beginning to show.

Researchers scanning 10 million webpages have found that nearly 10,000 pages contained live API credentials left in plain sight, potentially exposing access to services from cloud platforms to payment ...

Unicycive Therapeutics (UNCY) is rated as a speculative Buy with a scenario-weighted $10 price target, implying ~75% upside.

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings.